Tag: Axel Hauschild

Sanofi, Regeneron secure Libtayo EMA approval for a type of skin cancer

pharmanewsdaily- July 21, 2019

Libtayo EMA approval : The European Commission has given conditional approval for Libtayo (cemiplimab) for the treatment of adult patients with metastatic or locally advanced ... Read More